Medical - Care Facilities
Compare Stocks
4 / 10Stock Comparison
HCSG vs BGSF vs KELYA vs TBI
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
Staffing & Employment Services
Staffing & Employment Services
HCSG vs BGSF vs KELYA vs TBI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Care Facilities | Staffing & Employment Services | Staffing & Employment Services | Staffing & Employment Services |
| Market Cap | $1.60B | $58M | $349M | $182M |
| Revenue (TTM) | $1.84B | $51M | $3.09B | $1.25B |
| Net Income (TTM) | $59M | $-11M | $-266M | $-53M |
| Gross Margin | 13.3% | 35.9% | 26.3% | 28.4% |
| Operating Margin | 3.0% | -21.7% | -2.8% | -2.6% |
| Forward P/E | 20.8x | — | 11.0x | — |
| Total Debt | $25M | $2M | $159M | $171M |
| Cash & Equiv. | $161M | $19M | $33M | $25M |
HCSG vs BGSF vs KELYA vs TBI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| BGSF, Inc. (BGSF) | 100 | 49.8 | -50.2% |
| Kelly Services, Inc. (KELYA) | 100 | 64.7 | -35.3% |
| TrueBlue, Inc. (TBI) | 100 | 38.9 | -61.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCSG vs BGSF vs KELYA vs TBI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCSG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 7.1%, EPS growth 52.8%, 3Y rev CAGR 2.8%
- 7.1% revenue growth vs BGSF's -65.8%
- 3.2% margin vs BGSF's -21.2%
- 7.3% ROA vs BGSF's -12.6%, ROIC 9.0% vs -8.5%
BGSF is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 1 yrs, beta 0.95, yield 38.9%
- -15.8% 10Y total return vs HCSG's -26.8%
- Lower volatility, beta 0.95, Low D/E 3.4%, current ratio 4.12x
- Beta 0.95, yield 38.9%, current ratio 4.12x
KELYA is the clearest fit if your priority is value.
- Better valuation composite
TBI lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.1% revenue growth vs BGSF's -65.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 3.2% margin vs BGSF's -21.2% | |
| Stability / Safety | Beta 0.95 vs TBI's 1.13, lower leverage | |
| Dividends | 38.9% yield, 1-year raise streak, vs KELYA's 3.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +125.0% vs KELYA's -12.2% | |
| Efficiency (ROA) | 7.3% ROA vs BGSF's -12.6%, ROIC 9.0% vs -8.5% |
HCSG vs BGSF vs KELYA vs TBI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HCSG vs BGSF vs KELYA vs TBI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCSG leads in 3 of 6 categories
KELYA leads 1 • BGSF leads 0 • TBI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HCSG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KELYA is the larger business by revenue, generating $3.1B annually — 60.6x BGSF's $51M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to BGSF's -21.2%. On growth, HCSG holds the edge at +6.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $51M | $3.1B | $1.2B |
| EBITDAEarnings before interest/tax | $72M | -$11M | -$54M | -$10M |
| Net IncomeAfter-tax profit | $59M | -$11M | -$266M | -$53M |
| Free Cash FlowCash after capex | $139M | -$987,000 | $66M | -$60M |
| Gross MarginGross profit ÷ Revenue | +13.3% | +35.9% | +26.3% | +28.4% |
| Operating MarginEBIT ÷ Revenue | +3.0% | -21.7% | -2.8% | -2.6% |
| Net MarginNet income ÷ Revenue | +3.2% | -21.2% | -8.6% | -4.3% |
| FCF MarginFCF ÷ Revenue | +7.6% | -1.9% | +2.1% | -4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | -67.0% | -100.0% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +175.0% | +100.0% | -2.1% | -37.5% |
Valuation Metrics
KELYA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, HCSG's 22.4x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.6B | $58M | $349M | $182M |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $41M | $475M | $329M |
| Trailing P/EPrice ÷ TTM EPS | 27.54x | -7.43x | -1.34x | -3.73x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.83x | — | 10.96x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 22.38x | — | — | 160.03x |
| Price / SalesMarket cap ÷ Revenue | 0.87x | 0.63x | 0.08x | 0.11x |
| Price / BookPrice ÷ Book value/share | 3.19x | 1.20x | 0.35x | 0.65x |
| Price / FCFMarket cap ÷ FCF | 11.49x | — | 3.06x | — |
Profitability & Efficiency
HCSG leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-25 for KELYA. BGSF carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to TBI's 0.62x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs TBI's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.8% | -19.3% | -24.6% | -18.7% |
| ROA (TTM)Return on assets | +7.3% | -12.6% | -11.3% | -8.1% |
| ROICReturn on invested capital | +9.0% | -8.5% | -4.0% | -5.2% |
| ROCEReturn on capital employed | +7.7% | -10.8% | -4.3% | -5.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.05x | 0.03x | 0.16x | 0.62x |
| Net DebtTotal debt minus cash | -$136M | -$17M | $126M | $146M |
| Cash & Equiv.Liquid assets | $161M | $19M | $33M | $25M |
| Total DebtShort + long-term debt | $25M | $2M | $159M | $171M |
| Interest CoverageEBIT ÷ Interest expense | 33.02x | -2.88x | -12.07x | -46.19x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HCSG five years ago would be worth $7,888 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, BGSF leads with a +125.0% total return vs KELYA's -12.2%. The 3-year compound annual growth rate (CAGR) favors HCSG at 14.1% vs TBI's -26.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.6% | +11.3% | +13.1% | +36.6% |
| 1-Year ReturnPast 12 months | +55.8% | +125.0% | -12.2% | +51.0% |
| 3-Year ReturnCumulative with dividends | +48.6% | -20.4% | -34.2% | -60.2% |
| 5-Year ReturnCumulative with dividends | -21.1% | -32.2% | -58.3% | -78.7% |
| 10-Year ReturnCumulative with dividends | -26.8% | -15.8% | -33.0% | -68.4% |
| CAGR (3Y)Annualised 3-year return | +14.1% | -7.3% | -13.0% | -26.4% |
Risk & Volatility
Evenly matched — HCSG and BGSF each lead in 1 of 2 comparable metrics.
Risk & Volatility
BGSF is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs BGSF's 63.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.95x | 1.01x | 1.13x |
| 52-Week HighHighest price in past year | $24.39 | $8.22 | $14.94 | $7.78 |
| 52-Week LowLowest price in past year | $12.66 | $3.20 | $7.98 | $3.18 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +63.3% | +64.9% | +77.2% |
| RSI (14)Momentum oscillator 0–100 | 61.8 | 29.8 | 63.7 | 83.2 |
| Avg Volume (50D)Average daily shares traded | 676K | 22K | 361K | 386K |
Analyst Outlook
Evenly matched — HCSG and BGSF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HCSG as "Hold", KELYA as "Buy", TBI as "Buy". Consensus price targets imply 54.6% upside for KELYA (target: $15) vs -4.3% for TBI (target: $6). For income investors, BGSF offers the higher dividend yield at 38.85% vs KELYA's 3.23%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — | Buy | Buy |
| Price TargetConsensus 12-month target | $24.50 | — | $15.00 | $5.75 |
| # AnalystsCovering analysts | 15 | — | 5 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +38.9% | +3.2% | — |
| Dividend StreakConsecutive years of raises | 20 | 1 | 5 | 0 |
| Dividend / ShareAnnual DPS | — | $2.02 | $0.31 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | +2.6% | +3.5% | +0.6% |
HCSG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). KELYA leads in 1 (Valuation Metrics). 2 tied.
HCSG vs BGSF vs KELYA vs TBI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HCSG or BGSF or KELYA or TBI a better buy right now?
For growth investors, Healthcare Services Group, Inc.
(HCSG) is the stronger pick with 7. 1% revenue growth year-over-year, versus -65. 8% for BGSF, Inc. (BGSF). Healthcare Services Group, Inc. (HCSG) offers the better valuation at 27. 5x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate Kelly Services, Inc. (KELYA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCSG or BGSF or KELYA or TBI?
On forward P/E, Kelly Services, Inc.
is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HCSG or BGSF or KELYA or TBI?
Over the past 5 years, Healthcare Services Group, Inc.
(HCSG) delivered a total return of -21. 1%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: BGSF returned -15. 8% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCSG or BGSF or KELYA or TBI?
By beta (market sensitivity over 5 years), BGSF, Inc.
(BGSF) is the lower-risk stock at 0. 95β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 19% more volatile than BGSF relative to the S&P 500. On balance sheet safety, BGSF, Inc. (BGSF) carries a lower debt/equity ratio of 3% versus 62% for TrueBlue, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCSG or BGSF or KELYA or TBI?
By revenue growth (latest reported year), Healthcare Services Group, Inc.
(HCSG) is pulling ahead at 7. 1% versus -65. 8% for BGSF, Inc. (BGSF). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, HCSG leads at 2. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCSG or BGSF or KELYA or TBI?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -8. 3% for BGSF, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCSG leads at 2. 6% versus -10. 0% for BGSF. At the gross margin level — before operating expenses — BGSF leads at 34. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCSG or BGSF or KELYA or TBI more undervalued right now?
On forward earnings alone, Kelly Services, Inc.
(KELYA) trades at 11. 0x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 9. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 54. 6% to $15. 00.
08Which pays a better dividend — HCSG or BGSF or KELYA or TBI?
In this comparison, BGSF (38.
9% yield), KELYA (3. 2% yield) pay a dividend. HCSG, TBI do not pay a meaningful dividend and should not be held primarily for income.
09Is HCSG or BGSF or KELYA or TBI better for a retirement portfolio?
For long-horizon retirement investors, BGSF, Inc.
(BGSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 95), 38. 9% yield). Both have compounded well over 10 years (BGSF: -15. 8%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCSG and BGSF and KELYA and TBI?
These companies operate in different sectors (HCSG (Healthcare) and BGSF (Industrials) and KELYA (Industrials) and TBI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCSG is a small-cap quality compounder stock; BGSF is a small-cap income-oriented stock; KELYA is a small-cap income-oriented stock; TBI is a small-cap quality compounder stock. BGSF, KELYA pay a dividend while HCSG, TBI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.